These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9507951)

  • 1. Transferrin C2, metal binding and Alzheimer's disease.
    Van Landeghem GF; Sikström C; Beckman LE; Adolfsson R; Beckman L
    Neuroreport; 1998 Jan; 9(2):177-9. PubMed ID: 9507951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency of the transferrin C2 subtype in Alzheimer's disease.
    van Rensburg SJ; Carstens ME; Potocnik FC; Aucamp AK; Taljaard JJ
    Neuroreport; 1993 Sep; 4(11):1269-71. PubMed ID: 8219026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferrin C2 and Alzheimer's disease: another piece of the puzzle found?
    Van Rensburg SJ; Carstens ME; Potocnik FC; van der Spuy G; van der Walt BJ; Taljaard JJ
    Med Hypotheses; 1995 Apr; 44(4):268-72. PubMed ID: 7666827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5- and 6-glycosylation of transferrin in patients with Alzheimer's disease.
    van Rensburg SJ; Berman P; Potocnik F; MacGregor P; Hon D; de Villiers N
    Metab Brain Dis; 2004 Jun; 19(1-2):89-96. PubMed ID: 15214509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferrin gene polymorphism in Alzheimer's disease and dementia with Lewy bodies in humans.
    Hussain RI; Ballard CG; Edwardson JA; Morris CM
    Neurosci Lett; 2002 Jan; 317(1):13-6. PubMed ID: 11750985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C2 variant of human serum transferrin retains the iron binding properties of the native protein.
    Zatta P; Messori L; Mauri P; van Rensburg SJ; van Zyl J; Gabrielli S; Gabbiani C
    Biochim Biophys Acta; 2005 Sep; 1741(3):264-70. PubMed ID: 15975770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferrin types, iron-binding capacity and body iron stores.
    Sikström C; Beckman L; Hallmans G; Asplund K
    Hum Hered; 1993; 43(6):337-41. PubMed ID: 8288264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylation of transferrin in Alzheimer's disease and alcohol-induced dementia.
    van Rensburg SJ; Berman PA; Potocnik FC; Taljaard JJ
    Metab Brain Dis; 2000 Dec; 15(4):243-7. PubMed ID: 11383548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease.
    Robson KJ; Lehmann DJ; Wimhurst VL; Livesey KJ; Combrinck M; Merryweather-Clarke AT; Warden DR; Smith AD
    J Med Genet; 2004 Apr; 41(4):261-5. PubMed ID: 15060098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aluminum and Alzheimer's Disease.
    Colomina MT; Peris-Sampedro F
    Adv Neurobiol; 2017; 18():183-197. PubMed ID: 28889268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallium (aluminium) transferrin binding in Alzheimer's disease.
    Farrar G; Altmann P; Hodgkins P; Blair JA
    Lancet; 1992 Feb; 339(8788):302-3. PubMed ID: 1346299
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new inducible transferrin-independent iron uptake system involved with aluminum accumulation in the brain of patients with Alzheimer's disease].
    Oshiro S
    Tanpakushitsu Kakusan Koso; 1995 Aug; 40(11):1738-43. PubMed ID: 7676035
    [No Abstract]   [Full Text] [Related]  

  • 13. Earlier age of onset of Alzheimer's disease in patients with both the transferrin C2 and apolipoprotein E-epsilon 4 alleles.
    van Rensburg SJ; Potocnik FC; De Villiers JN; Kotze MJ; Taljaard JJ
    Ann N Y Acad Sci; 2000 Apr; 903():200-3. PubMed ID: 10818508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin-gallium binding in Alzheimer's disease.
    Lancet; 1991 Nov; 338(8779):1394-6. PubMed ID: 1682757
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical model for inflammation of the brain: the effect of iron and transferrin on monocytes and lipid peroxidation.
    van Rensburg SJ; van Zyl J; Hon D; Daniels W; Hendricks J; Potocnik F; Erasmus R
    Metab Brain Dis; 2004 Jun; 19(1-2):97-112. PubMed ID: 15214510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial cells contribute more to iron and aluminum accumulation but are more resistant to oxidative stress than neuronal cells.
    Oshiro S; Kawahara M; Kuroda Y; Zhang C; Cai Y; Kitajima S; Shirao M
    Biochim Biophys Acta; 2000 Nov; 1502(3):405-14. PubMed ID: 11068183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative binding study of aluminum and chromium to human transferrin. Effect of iron.
    Moshtaghie AA; Ani M; Bazrafshan MR
    Biol Trace Elem Res; 1992; 32():39-46. PubMed ID: 1375080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the effect of aluminum in drinking water and transferrin C2 allele on Alzheimer's disease.
    Rondeau V; Iron A; Letenneur L; Commenges D; Duchêne F; Arveiler B; Dartigues JF
    Eur J Neurol; 2006 Sep; 13(9):1022-5. PubMed ID: 16930371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competition of iron and aluminum for transferrin: the molecular basis for aluminum deposition in iron-overloaded dialysis patients?
    Van Landeghem GF; D'Haese PC; Lamberts LV; De Broe ME
    Exp Nephrol; 1997; 5(3):239-45. PubMed ID: 9208284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new model for the pathophysiology of Alzheimer's disease. Aluminium toxicity is exacerbated by hydrogen peroxide and attenuated by an amyloid protein fragment and melatonin.
    van Rensburg SJ; Daniels WM; Potocnik FC; van Zyl JM; Taljaard JJ; Emsley RA
    S Afr Med J; 1997 Sep; 87(9):1111-5. PubMed ID: 9358827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.